Simplified management protocol for term neonates after prolonged rupture of membranes in a setting with high rates of neonatal sepsis and mortality: a quality improvement study.
Adult
Amoxicillin
/ therapeutic use
Anti-Bacterial Agents
/ therapeutic use
Antibiotic Prophylaxis
Clinical Protocols
Developing Countries
Drug Resistance, Bacterial
Female
Fetal Membranes, Premature Rupture
/ drug therapy
Follow-Up Studies
Gentamicins
/ therapeutic use
Humans
Infant, Newborn
Injections, Intramuscular
Male
Medical Overuse
/ prevention & control
Neonatal Sepsis
/ drug therapy
Papua New Guinea
/ epidemiology
Pregnancy
Prenatal Care
Prospective Studies
Quality Improvement
Young Adult
antibiotic resistance
low and middle income country
neonatal sepsis
prolonged rupture of membranes
quality improvement
Journal
Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
08
07
2018
revised:
06
11
2018
accepted:
14
11
2018
pubmed:
26
11
2018
medline:
26
11
2019
entrez:
26
11
2018
Statut:
ppublish
Résumé
In low-income and middle-income countries, courses of antibiotics are routinely given to term newborns whose mothers had prolonged rupture of membranes (PROM). Rational antibiotic use is vital given rising rates of antimicrobial resistance and potential adverse effects of antibiotic exposure in newborns. However missing cases of sepsis can be life-threatening.This is a quality improvement evaluation of a protocol for minimal or no antibiotics in term babies born after PROM in Papua New Guinea. Asymptomatic, term babies born to women with PROM >12 hours prior to birth were given a stat dose of antibiotics, or no antibiotics if the mother had received intrapartum antibiotics, reviewed and discharged at 48-72 hours with follow-up. Clinical signs of sepsis within the first week and the neonatal period were assessed. Of 170 newborns whose mothers had PROM, 133 were assessed at 7 days: signs of sepsis occurred in 10 babies (7.5%; 95% CI 4.4% to 13.2%) in the first week. Five had isolated fever, four had skin pustules and one had fever with periumbilical erythema. An additional four (3%) had any sign of sepsis between 8 and 28 days. There was one case of bacteraemia and no deaths. 37 were lost to follow-up, but hospital records did not identify any subsequent admissions for infection. A rate of sepsis was documented that was comparable with other studies in low-income countries. This protocol may reduce antimicrobial resistance and consequences of antibiotic exposure in newborns, provided safeguards are in place to monitor for signs of sepsis.
Identifiants
pubmed: 30472663
pii: archdischild-2018-315826
doi: 10.1136/archdischild-2018-315826
pmc: PMC6362436
doi:
Substances chimiques
Anti-Bacterial Agents
0
Gentamicins
0
Amoxicillin
804826J2HU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
115-120Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Pediatrics. 2008 Apr;121(4):697-702
pubmed: 18381533
Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003957
pubmed: 15495071
S Afr Med J. 1976 Apr 3;50(15):574-6
pubmed: 772827
Pediatr Infect Dis J. 2012 Jan;31(1):89-90
pubmed: 21860336
Arch Dis Child. 2016 Apr;101(4):392-7
pubmed: 26489801
P N G Med J. 2012 Mar-Dec;55(1-4):5-11
pubmed: 25338469
J Trop Pediatr. 2015 Feb;61(1):1-13
pubmed: 25604489
P N G Med J. 2000 Mar-Jun;43(1-2):82-90
pubmed: 11407623
Obstet Gynecol. 1996 Feb;87(2):188-94
pubmed: 8559521
P N G Med J. 2009 Mar-Jun;52(1-2):28-34
pubmed: 21125988
J Antimicrob Chemother. 2018 Mar 1;73(3):569-580
pubmed: 29182785
Semin Perinatol. 2003 Jun;27(3):217-30
pubmed: 12889589
J Obstet Gynaecol. 2007 Jan;27(1):37-40
pubmed: 17365456
Obstet Gynecol. 2007 Sep;110(3):612-8
pubmed: 17766608
Pediatrics. 2006 Jan;117(1):67-74
pubmed: 16396862
J Infect Dev Ctries. 2014 Jan 15;8(1):67-73
pubmed: 24423714
J Obstet Gynaecol Can. 2009 Sep;31(9):863-867
pubmed: 19941711
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):635-9
pubmed: 9757963
Early Hum Dev. 2011 Jun;87(6):391-9
pubmed: 21419584
J Perinat Med. 2013 Nov;41(6):647-9
pubmed: 23828422